Royalty Pharma plc
RPRX
Kedudukan dalam Saham
#893
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$60.62
Modal Pasaran
$26.99B
Perubahan (1 hari)
-0.56%
Perubahan (1 tahun)
63.79%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Sejarah dividen untuk Royalty Pharma plc (RPRX)
Royalty Pharma plc (simbol saham: RPRX) telah membuat sejumlah 23 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $4.50
Hasil dividen (TTM): 0.0157
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $4.50
Hasil dividen (TTM): 0.0157
Pembayaran dividen untuk Royalty Pharma plc (RPRX) dari 2020 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (diselaraskan untuk pemecahan saham) | Ubah |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Senarai semua pembayaran dividen
| Tahun | Dividen | Ubah |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Pembayaran dividen untuk syarikat serupa atau pesaing
| Syarikat | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
|
| 69.00% |
HK
|
